Company record
Accriva Diagnostics, Inc.
0 FDA warning letters since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Accriva Diagnostics, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Accriva Diagnostics, Inc. Device |
Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103 Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis. |
| Jun 24 | Class II | Accriva Diagnostics, Inc. Device |
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2 Assayed Whole blood control contains labeling with incorrect performance range. |
| Dec 10, 2025 | Class II | Accriva Diagnostics, Inc. Device |
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling. |
| Nov 19, 2025 | Class III | Accriva Diagnostics, Inc. Device |
VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 rece⦠Due to an device without a premarket clearance being incorrectly package and distributed. |